-Enrollment ongoing in clinical trials of CTX001™ for patients with severe hemoglobinopathies--Enrollment ongoing in clinical trial of CTX110™, targeting CD19+ […]
New independent Director will enhance diversity of expertise within AMG’s Board of DirectorsNathaniel Dalton and Niall Ferguson announce their intention […]